These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38860897)

  • 1. AmyloidPETNet: Classification of Amyloid Positivity in Brain PET Imaging Using End-to-End Deep Learning.
    Fan S; Ponisio MR; Xiao P; Ha SM; Chakrabarty S; Lee JJ; Flores S; LaMontagne P; Gordon B; Raji CA; Marcus DS; Nazeri A; Ances BM; Bateman RJ; Morris JC; Benzinger TLS; Sotiras A;
    Radiology; 2024 Jun; 311(3):e231442. PubMed ID: 38860897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Deep Learning to Predict Standardized Uptake Value Ratio and Amyloid Status on
    Reith F; Koran ME; Davidzon G; Zaharchuk G;
    AJNR Am J Neuroradiol; 2020 Jun; 41(6):980-986. PubMed ID: 32499247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data.
    Iaccarino L; La Joie R; Koeppe R; Siegel BA; Hillner BE; Gatsonis C; Whitmer RA; Carrillo MC; Apgar C; Camacho MR; Nosheny R; Rabinovici GD;
    Neuroimage; 2022 Feb; 246():118775. PubMed ID: 34890793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-based Deep Learning Assessment of Amyloid, Tau, and Neurodegeneration Biomarker Status across the Alzheimer Disease Spectrum.
    Lew CO; Zhou L; Mazurowski MA; Doraiswamy PM; Petrella JR;
    Radiology; 2023 Oct; 309(1):e222441. PubMed ID: 37815445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.
    Okada Y; Kato T; Iwata K; Kimura Y; Nakamura A; Hattori H; Toyama H; Ishii K; Ishii K; Senda M; Ito K; Iwatsubo T;
    Ann Nucl Med; 2020 Feb; 34(2):108-118. PubMed ID: 31749127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using
    Ding Y; Sohn JH; Kawczynski MG; Trivedi H; Harnish R; Jenkins NW; Lituiev D; Copeland TP; Aboian MS; Mari Aparici C; Behr SC; Flavell RR; Huang SY; Zalocusky KA; Nardo L; Seo Y; Hawkins RA; Hernandez Pampaloni M; Hadley D; Franc BL
    Radiology; 2019 Feb; 290(2):456-464. PubMed ID: 30398430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-rater variability of visual interpretation and comparison with quantitative evaluation of
    Yamane T; Ishii K; Sakata M; Ikari Y; Nishio T; Ishii K; Kato T; Ito K; Senda M;
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):850-857. PubMed ID: 27966045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases.
    Son HJ; Oh JS; Oh M; Kim SJ; Lee JH; Roh JH; Kim JS
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):332-341. PubMed ID: 31811343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach.
    Royse SK; Minhas DS; Lopresti BJ; Murphy A; Ward T; Koeppe RA; Bullich S; DeSanti S; Jagust WJ; Landau SM;
    Alzheimers Res Ther; 2021 May; 13(1):99. PubMed ID: 33971965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of amyloid PET using
    Matsuda H; Okita K; Motoi Y; Mizuno T; Ikeda M; Sanjo N; Murakami K; Kambe T; Takayama T; Yamada K; Suehiro T; Matsunaga K; Yokota T; Tateishi U; Shigemoto Y; Kimura Y; Chiba E; Kawashima T; Tomo Y; Tachimori H; Kimura Y; Sato N
    Ann Nucl Med; 2022 Dec; 36(12):1039-1049. PubMed ID: 36194355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMYQ: An index to standardize quantitative amyloid load across PET tracers.
    Pegueroles J; Montal V; Bejanin A; Vilaplana E; Aranha M; Santos-Santos MA; Alcolea D; Carrió I; Camacho V; Blesa R; Lleó A; Fortea J; ;
    Alzheimers Dement; 2021 Sep; 17(9):1499-1508. PubMed ID: 33797846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
    Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
    J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of
    Reinartz M; Luckett ES; Schaeverbeke J; De Meyer S; Adamczuk K; Thal DR; Van Laere K; Dupont P; Vandenberghe R
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3772-3786. PubMed ID: 35522322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC).
    Chincarini A; Peira E; Morbelli S; Pardini M; Bauckneht M; Arbizu J; Castelo-Branco M; Büsing KA; de Mendonça A; Didic M; Dottorini M; Engelborghs S; Ferrarese C; Frisoni GB; Garibotto V; Guedj E; Hausner L; Hugon J; Verhaeghe J; Mecocci P; Musarra M; Queneau M; Riverol M; Santana I; Guerra UP; Nobili F
    Neuroimage Clin; 2019; 23():101846. PubMed ID: 31077984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
    Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
    Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-Low-Dose
    Chen KT; Gong E; de Carvalho Macruz FB; Xu J; Boumis A; Khalighi M; Poston KL; Sha SJ; Greicius MD; Mormino E; Pauly JM; Srinivas S; Zaharchuk G
    Radiology; 2019 Mar; 290(3):649-656. PubMed ID: 30526350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation.
    Nayate AP; Dubroff JG; Schmitt JE; Nasrallah I; Kishore R; Mankoff D; Pryma DA;
    AJNR Am J Neuroradiol; 2015 Jul; 36(7):1237-44. PubMed ID: 25767185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Analysis of Two Automated Quantification Methods for Regional Cerebral Amyloid Retention: PET-Only and PET-and-MRI-Based Methods.
    Kim S; Wang SM; Kang DW; Um YH; Han EJ; Park SY; Ha S; Choe YS; Kim HW; Kim RE; Kim D; Lee CU; Lim HK
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a Universal Readout for
    Bischof GN; Bartenstein P; Barthel H; van Berckel B; Doré V; van Eimeren T; Foster N; Hammes J; Lammertsma AA; Minoshima S; Rowe C; Sabri O; Seibyl J; Van Laere K; Vandenberghe R; Villemagne V; Yakushev I; Drzezga A
    J Nucl Med; 2021 Jul; 62(7):999-1005. PubMed ID: 33712532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.